DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



[Tranylcypromine for chronic therapy-resistant agoraphobia with panic disorder and recurrent depressive disorder].

Author(s): Boerner RJ, Luhring F

Affiliation(s): Zentrum fur Psychologische und Psychosoziale Medizin, Christliches Krankenhaus Quakenbruck GmbH, Akademisches Lehrkrankenhaus der MHH, Quakenbruck. r.boerner@ckq-gmbh.de

Publication date & source: 2010-10, Psychiatr Prax., 37(7):350-2. Epub 2010 Aug 11.

Publication type: Case Reports; English Abstract

OBJECTIVE: Tranylcypromine has been recommend as an option for therapy-resistant depressive and anxiety disorders. In this case report the effectiveness of this medication as a part of a combined therapy-program including pharmacological, behavioural and psychodynamic interventions could be demonstrated on an outpatient with a therapy-resistant depression and agoraphobia. METHODS: The development of the illness, clinical symptoms and the 4 year ongoing therapy of a 69-year old patient are described in detail. RESULTS/CONCLUSION: After the failure of 13 antidepressant agents with considerable side effects, a one year sustained remission of depression as well as great improvement of agoraphobia could be achieved with tranylcypromine. In this situation, tranylcypromine showed itself, for the first time, to be a very effective and well tolerated antidepressant. (c) Georg Thieme Verlag KG Stuttgart . New York.

Page last updated: 2011-12-09

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017